From: Overexpression of CLC-3 is regulated by XRCC5 and is a poor prognostic biomarker for gastric cancer
Variables | N | XRCC5 | χ 2 | P value | |
---|---|---|---|---|---|
Low expression | High expression | ||||
Age | |||||
 ≤ 70 | 55 | 33 | 22 | 3.429 | 0.064 |
 > 70 | 35 | 14 | 21 | ||
Gender | |||||
 Male | 70 | 34 | 36 | 1.683 | 0.195 |
 Female | 20 | 13 | 7 | ||
Pathological grade | |||||
 I/II | 24 | 9 | 15 | 2.843 | 0.092 |
 III/IV | 66 | 38 | 28 | ||
Depth of invasion | |||||
 T1/T2 | 11 | 9 | 2 | 4.399 | 0.036 |
 T3/T4 | 79 | 38 | 41 | ||
Lymph node metastases | |||||
 N0 | 23 | 14 | 9 | 0.926 | 0.336 |
 N1/N2/N3 | 67 | 33 | 34 | ||
Distant metastasis | |||||
 M0 | 86 | 46 | 40 | 1.243 | 0.265 |
 M1 | 4 | 1 | 3 | ||
TNM stage | |||||
 I/II | 37 | 24 | 13 | 4.025 | 0.045 |
 III/IV | 53 | 23 | 30 |